Posts

Showing posts from August, 2022

Colostrum To Help Lower Blood Pressure Jewish Ledger - Connecticut Jewish Ledger

Image
(ET, ) - It was the most watched episode in Shark Tank history when sisters Anna and Samantha Martin won over the Shark Tank panel. N ever before had the judging panel unanimously decided to each invest millions of dollars into a potential company. After buying a staggering 25% share in the sisters' company, the Shark Tank panel have personally mentored the pair, helping them undergo re-branding and re-packing of their miracle product. Touting their discovery as "the greatest step forward in weight-loss history," the judges were quick to offer up their hard earned cash to back the entrepreneurial pair. "We were shocked. The most we were hoping for was some advice…we weren't even sure that we would manage to get any investors," explained Samantha. After outstanding offers from each panel member, the sisters burst into tears. "It didn't feel real. The fact tha

Xalatan (Latanoprost) – Ophthalmic: Uses, Side Effects - Verywell Health

Image
What Is Xalatan? Xalatan is a prescription eye drop medicine used to treat adults with open-angle glaucoma or ocular hypertension (increased pressure in the eye). Xalatan belongs to a group of drugs called prostaglandin analogs. It lowers eye pressure by increasing the flow of fluid out of the eye. Drug Facts Generic Name : Latanoprost Brand Name(s) : Xalatan Drug Availability : Prescription Therapeutic Classification : Prostaglandin analog Available Generically : Yes Controlled Substance : No Administration Route : Ophthalmic Active Ingredient : Latanoprost Dosage Form(s) : Eye drops What Is Xalatan Used For? Xalatan is a medication used to treat open-angle glaucoma and ocular hypertension (increased pressure in the eye) in adults. Glaucoma is a group of diseases that damage the optic nerve in the eye. It affects about 3 million people in the United States. Open-angle glaucoma

Acyclovir Market 2022 Projected to Show Strong Growth to 2030 | SYNMEDIC LABORATORIES, GEO PHARMA PVT LTD – Muleskinner - Muleskinner

Image
New York, United States – Key Companies Covered in the Acyclovir Research are ZEE LABORATORIES LTD, NOVUS LIFE SCIENCES PVT LTD, SYNMEDIC LABORATORIES, GEO PHARMA PVT LTD, TALENT LABORATORIES, AGIO PHARMACEUTICALS LIMITED, BHAVISHYA PHARMACEUTICALS PVT LTD, CIPLA INC., ADLEY FORMULATION, FINECURE PHARMACEUTICALS LTD and other key market players. The Acyclovir market revenue was $$ Million USD in 2016, grew to $$ Million USD in 2020, and will reach $$ Million USD in 2030, with a CAGR of % during 2022-2030. Market Overview It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Global Acyclovir Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Acyclovir industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis

Adenosine Modulators and Calcium Channel Blockers in Bipolar Disorder Treatment - Psychiatry Advisor

Image
A decreased risk for psychiatric hospitalization in bipolar disorder was associated with specific calcium channel blockers, diltiazem, and dihydropyridines. Results were inconclusive for this risk associated with the adenosine modulators, allopurinol and dipyridamole. These were among the study findings published in the Journal of Affective Disorders. Treatment of bipolar disorder remains problematic with inadequate response, medication resistance, and significant costs. Drug repurposing vs traditional drug development is a faster, lower cost, less risky avenue to discover possible new pharmacotherapies. Researchers sought to determine the risk for psychiatric hospitalization among individuals with bipolar disorder associated with their exposure to specific calcium channel blockers (CCBs) and adenosine modulators. They conducted a nationwide observational cohort study of individuals in Finland identified from the inpatient, specialized outpatient, sick

Dosing Adjunctive Aripiprazole for Treatment-Refractory Depression - Psychiatric Times

Image
What is the optimal dose of aripiprazole as augmentation for treatment-refractory depression? Researchers performed a systematic review and dose-effect meta-analysis. CASE VIGNETTE "Mrs Norbert" is a 32-year-old Hispanic female with a history of recurrent major depressive disorder, with illness onset in her teens. She failed previous trials, with adequate dose and duration, of citalopram and sertraline ("felt worse"). She experienced some benefit with bupropion extended-released, titrated to 450 mg/day, although she has significant residual symptoms of depression. Subsequently, she failed a trial of adjunctive lithium due to tolerability concerns (nausea, diarrhea, and increased thirst). Her psychiatrist started adjunctive oral aripiprazole 10 mg daily. She reported improvements in depressed mood, irritability, energy, suicidal ideation, and overvalued ideas that people are generally against her in the first 2 weeks of treatment. The improvement was maintained after

Roundup: Fred launches third-party apps marketplace and more briefs - Mobihealth News

Image
Fred launches third-party apps marketplace for pharmacies Australian pharmacy IT solutions provider Fred IT Group has launched an online marketplace of third-party applications for pharmacies. Called Fred Marketplace, the web-based hub has solutions that have been approved and tested for use with Fred's software, including apps and integrations for robots, eCommerce, business intelligence, clinical services, drug information and medication management, loyalty and payment. Third-party solutions come from Fred's trusted vendor partners, namely BD, Dataology, GuildLink, LifeSmart, MIMs, Modeus, Storbie, StrongRoom, Tyro, and Willach Pharmacy Solutions.  The marketplace will continue to bring on new software partners and approved applications as it expands. University of South Australia researchers develop fibre sensors to remotely monitor patients Scientists from the University of South Australia have developed tiny optical fibre sensors to remotely track the po

Three Flu Season Imperatives: Vaccinate the Young, the Old, and Everyone in Between - Patient Care Online

Image
Flu season in the southern hemisphere came early this year, and continues to be a substantial one, said William Schaffner, MD, in a recent interview with Patient Care © . Interestingly, he added, children this year seem to be disproportionaltely affected. Schaffner, a well-known infectious disease expert from Vanderbilt University School of Medicine and medical director of the National Foundation for Infectious Diseases, made the observation while offering his guidance to US primary care clinicians on the respiratory virus season now on the horizon. Everyone older than age 6 months should recieve vaccination against influenza, he re-emphasizes, and this year the Advisory Committee on Immunization Practices preferrentially recommends a high-dose or adjuvanted flu shot for adults aged ≥65 years. The full conversation follows here. William Schaffner, MD, is medical director of the National Foundation for Infectious Diseases, professor of preventive medicine in the Department of Health Pol

Abacavir/Lamivudine Viatris (abacavir and lamivudine) Drug / Medicine Information - News-Medical.Net

Image
abacavir (as sulfate) and lamivudine CONSUMER MEDICINE INFORMATION PATIENTS TAKING ABACAVIR/LAMIVUDINE VIATRIS, WHICH CONTAINS ABACAVIR, MAY DEVELOP A HYPERSENSITIVITY REACTION (SERIOUS ALLERGIC REACTION) WHICH CAN BE LIFE-THREATENING IF TREATMENT WITH ABACAVIR/LAMIVUDINE VIATRIS IS CONTINUED. CONTACT YOUR DOCTOR IMMEDIATELY FOR ADVICE ON WHETHER YOU SHOULD STOP TAKING ABACAVIR/LAMIVUDINE VIATRIS IF: 1) YOU GET A SKIN RASH OR 2) YOU GET ONE OR MORE SYMPTOMS FROM AT LEAST TWO OF THE FOLLOWING GROUPS: FEVER SHORTNESS OF BREATH, SORE THROAT OR COUGH NAUSEA OR VOMITING OR DIARRHOEA OR ABDOMINAL PAIN SEVERE TIREDNESS OR ACHINESS OR GENERALLY ILL FEELING IF YOU HAVE HAD A HYPERSENSITIVITY (ALLERGIC) REACTION TO ABACAVIR/LAMIVUDINE VIATRIS TABLETS, NEVER TAKE ABACA

Research review: prehospital TXA administration, side effects - EMS1.com

Image
With the use of tranexemic acid [TXA] increasing dramatically, it is important to understand how it works and what role it plays in the prehospital environment. How does coagulation work? Coagulation is the balance between clot formation and clot destruction. It's reasonable to consider prehospital TXA in trauma, especially in patients with incompressible bleeds, severe hypotension or who may require massive transfusion. (